Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
      0.18p
  • 52 Week High: 6.25p
  • 52 Week Low: 0.88p
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 324,167
  • Market Cap: £157.29m
  • RiskGrade: 268

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions) £ (Millions)
30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Continuing Operations        
Revenue 41.55 40.75 37.76 31.02
         
EBITDA 1.81 3.00 (4.93) (14.43)
Depreciation & Amortisation (1.70) (1.43) (1.32) (1.16)
         
Operating Profit/(Loss) 0.12 1.58 (6.25) (15.59)
Interest Payable (2.43) (1.58) (5.22) (4.85)
Interest Receivable/Investment Income n/a 0.01 0.03 0.20
         
Group Profit after Interest (2.31) n/a (11.44) (20.24)
Share of Assoc Cos/JV Profits n/a n/a n/a n/a
         
Profit Before Tax (2.31) n/a (11.44) (20.24)
Tax (0.35) 0.70 (0.33) (0.05)
         
Profit After Tax (2.66) 0.71 (11.76) (20.30)
         
Discontinued Operations        
Profit After Tax n/a n/a n/a n/a
         
PROFIT FOR PERIOD (2.66) 0.71 (11.76) (20.30)
         
Attributable to:        
Equity Holders of Parent Company (2.66) 0.71 (11.76) (20.30)
Minority Interests n/a n/a n/a n/a
         
Equity Dividends cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(2.66) c0.71 c(11.76) c(20.30)


Per Share Record - Normalised 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Continuing EPS        
Earnings per Share - Basic (0.86p) 0.24p (14.35p) (24.77p)
Earnings per Share - Diluted (0.86p) 0.23p (14.35p) (24.77p)
Earnings per Share - Adjusted (0.86p) 0.20p (14.35p) (24.80p)
Continuing and Discontinued EPS        
Earnings per Share - Basic (0.86p) 0.24p (14.35p) (24.77p)
Earnings per Share - Diluted (0.86p) 0.23p (14.35p) (24.77p)
Earnings per Share - Adjusted (0.86p) 0.20p (14.35p) (24.80p)
         
Dividend per Share n/a n/a n/a n/a


Key Financals 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Shares in Issue (millions)        
Shares in Issue - Year End 310.77 310.76 82.37 81.95
Weighted Average 310.76 293.14 81.99 81.95
Diluted 310.76 305.58 81.99 81.95
         
Performance Ratios        
Continuing Operations        
Operating Margin 0.28% 3.87% (16.54%) (50.26%)
Return on Capital Employed 0.86% 12.63% n/a n/a
Continuing Operations & Discontinued Operations        
Return on Equity (101.49%) 17.09% 51.37% 183.83%
         
Financial Status        
Continuing Operations        
Interest Cover - Continuing 0.05 1.00 (1.19) (3.17)
Revenue per Share 13.37p 13.90p 46.05p 37.85p
Pre-Tax Profit Per Share - Continuing (0.74p) n/a (13.95p) (24.70p)
         
Market Data        
Continuing Operations        
Earnings Per Share Growth - Basic n/a n/a n/a n/a
Earnings Per Share Growth - Diluted n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a 47.7 n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a
Continuing Operations & Discontinued Operations        
Earnings per Share - Company Adjusted n/a n/a n/a n/a
Earnings per Share - Diluted n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a 47.7 n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a
         
Market Capitalisation £ (Millions) 43.51 35.74 11.53 22.95
Dividend per Share n/a n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page